BioCentury | May 30, 2018
Distillery Therapeutics

Cancer

...CHP-486 and CHP-490, three small molecule Hsp70 inhibitors, in preclinical testing for bacterial infection. TARGET/MARKER/PATHWAY: DnaJ homolog...
BioCentury | Oct 27, 2016
Translation in Brief

Blueprint for fusion

...independently identifying the fusion oncogene between protein kinase cAMP-dependent catalytic α ( PRKACA ) and DnaJ homolog...
BioCentury | Sep 25, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Gaucher's disease DnaJ homolog subfamily B...
Items per page:
1 - 3 of 3